Cardiovascular Risk and Chronic Obstructive Pulmonary Disease
Cardiovascular disease contributes significantly to both morbidity and mortality in COPD. Shared risk factors for cardiovascular disease and COPD, such as smoking, low socioeconomic class, and a sedentary lifestyle contribute to the natural history of each of these conditions. novel mechanisms are involved in the pathogenesis of cardiovascular disease, and these may play an important role in driving the increased cardiovascular risk associated with COPD.
Related Conference of Cardiovascular Risk and Chronic Obstructive Pulmonary Disease
June 29-30, 2026
16th International Conference on Pulmonary & Respiratory Medicine
Aix-en-Provence, France
November 19-20, 2026
18th International Conference on Chronic Obstructive Pulmonary Disease
Dubai, UAE
Cardiovascular Risk and Chronic Obstructive Pulmonary Disease Conference Speakers
Recommended Sessions
- Lung Diseases
- Airway and Therapeutic Devices
- Asthma and allergy
- Cardiovascular Risk and Chronic Obstructive Pulmonary Disease
- CO-Morbidities in COPD
- COPD Exacerbations
- COPD Theraupetics
- Diagnostic Evaluation of COPD
- Environmental and Occupational lung Disease
- Epidemology of COPD
- Lung cancer
- Lung Transplantation
- Management of COPD
- Pathogenesis of COPD
- Pediatric Pulmonary,Critical care and Sleep
- Pulmonary diseases-treatment and therapies
- Pulmonary Hypertension
- Self-Management and Prevention of COPD
Related Journals
Are you interested in
- Advanced Lung Imaging - PULMONOLOGY 2026 (France)
- AI in Pulmonary Diagnostics - PULMONOLOGY 2026 (France)
- AI in Respiratory Care - COPD SUMMIT 2026 (Italy)
- Air Pollution & Tobacco Control - COPD SUMMIT 2026 (Italy)
- Asthma COPD Overlap (ACO) - COPD SUMMIT 2026 (Italy)
- Asthma: New Insights & Therapies - COPD SUMMIT 2026 (Italy)
- Bronchoscopy & Airway Techniques - COPD SUMMIT 2026 (Italy)
- COPD & Cardiovascular Diseases - COPD SUMMIT 2026 (Italy)
- COPD Diagnosis & Guidelines - COPD SUMMIT 2026 (Italy)
- COPD Innovations - PULMONOLOGY 2026 (France)
- COPD Pathogenesis - COPD SUMMIT 2026 (Italy)
- COPD Pharmacotherapy - COPD SUMMIT 2026 (Italy)
- COPD Prevention & Self-Management - COPD SUMMIT 2026 (Italy)
- COPD: Advances & Management - COPD SUMMIT 2026 (Italy)
- Critical Care Pulmonology - PULMONOLOGY 2026 (France)
- Cystic Fibrosis - COPD SUMMIT 2026 (Italy)
- Digital Respiratory Health - PULMONOLOGY 2026 (France)
- Environmental Lung Diseases - PULMONOLOGY 2026 (France)
- Interstitial Lung Diseases - PULMONOLOGY 2026 (France)
- Interventional Pulmonology - PULMONOLOGY 2026 (France)
- Interventional Pulmonology - COPD SUMMIT 2026 (Italy)
- Lung Cancer Biomarkers - PULMONOLOGY 2026 (France)
- Lung Cancer: Diagnosis & Treatment - COPD SUMMIT 2026 (Italy)
- Lung Fibrosis - COPD SUMMIT 2026 (Italy)
- Lung Transplantation - COPD SUMMIT 2026 (Italy)
- Mechanical Ventilation Strategies - PULMONOLOGY 2026 (France)
- Next-Gen COPD Treatments - COPD SUMMIT 2026 (Italy)
- Non-Invasive Ventilation (NIV) - COPD SUMMIT 2026 (Italy)
- Pediatric Pulmonology - PULMONOLOGY 2026 (France)
- Pediatric Respiratory Care - COPD SUMMIT 2026 (Italy)
- Personalized Pulmonary Medicine - COPD SUMMIT 2026 (Italy)
- Pneumonia & Tuberculosis - COPD SUMMIT 2026 (Italy)
- Precision Respiratory Medicine - PULMONOLOGY 2026 (France)
- Pulmonary Fibrosis Research - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - COPD SUMMIT 2026 (Italy)
- Pulmonary Rehabilitation - PULMONOLOGY 2026 (France)
- Pulmonary Rehabilitation - COPD SUMMIT 2026 (Italy)
- Respiratory Drug Delivery - PULMONOLOGY 2026 (France)
- Respiratory Infections - PULMONOLOGY 2026 (France)
- Respiratory Infections - COPD SUMMIT 2026 (Italy)
- Severe Asthma Therapies - PULMONOLOGY 2026 (France)
- Sleep & Breathing Disorders - PULMONOLOGY 2026 (France)
- Sleep Apnea - COPD SUMMIT 2026 (Italy)
- Thoracic Surgery Advances - PULMONOLOGY 2026 (France)
